Introduction. Reboxetine: a new selective antidepressant for the treatment of depression
Montgomery, S.A.; Schatzberg, A.F.
Journal of Clinical Psychiatry 59 Suppl. 14: 3
1998
ISSN/ISBN: 0160-6689 PMID: 9818622 Document Number: 496565
Document emailed within 1 workday
Related Documents
Devarajan, S.; Dursun, S.M. 2000: Citalopram plus reboxetine in treatment-resistant depression Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 45(5): 489-490Kadhe, N.G.; Chillar, A.J.; Deshmukh, Y.A. 2003: Reboxetine: a novel antidepressant Journal of Postgraduate Medicine 49(4): 373-375
Chue, P. 2000: Reboxetine and treatment-refractory elderly patients with depression Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 45(7): 669
Crown, W.H. 2000: Economic outcomes associated with tricyclic antidepressant and selective serotonin reuptake inhibitor treatments for depression Acta Psychiatrica Scandinavica. Supplementum 403: 62-66
Gillette, R.D.; Oxman, T.E. 1983: Tricyclic antidepressant drugs in the ambulatory treatment of depression Journal of Family Practice 17(2): 342-344
Nutt, D.J. 2006: The role of dopamine and norepinephrine in depression and antidepressant treatment Journal of Clinical Psychiatry 67(Suppl 6): 3-8
Jarema, M.; Dudek, D.; Landowski, J.; Heitzman, J.; Rabe-Jabłońska, J.; Rybakowski, J. 2011: Trazodon--the antidepressant: mechanism of action and its position in the treatment of depression Psychiatria Polska 45(4): 611-625
Srisurapanont, M.; Boonyanaruthee, V. 1997: Alprazolam and standard antidepressants in the treatment of depression: a meta-analysis of the antidepressant effect Journal of the Medical Association of Thailand 80(3): 183-188
Rybakowski, J.; Potok, E.; Strzyzewski, W.; Markowski, S. 1982: Cation fluxes in erythrocytes of patients with endogenous depression in the course of treatment with antidepressant drugs Polish Journal of Pharmacology and Pharmacy 34(5-6): 295-301
Agius, M.; Gardner, J.; Liu, K.; Zaman, R. 2010: An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications Psychiatria Danubina 22(2): 346-349
Komorousova, J.; Beran, J.; Rusavy, Z.; Jankovec, Z. 2010: Glycemic control improvement through treatment of depression using antidepressant drugs in patients with diabetes mellitus type 1 Neuro Endocrinology Letters 31(6): 801-806
Nurnberg, H.G.; Thompson, P.M.; Hensley, P.L. 1999: Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors Journal of Clinical Psychiatry 60(9): 574-579
Frank, E.; Grochocinski, V.J.; Spanier, C.A.; Buysse, D.J.; Cherry, C.R.; Houck, P.R.; Stapf, D.M.; Kupfer, D.J. 2000: Interpersonal psychotherapy and antidepressant medication: evaluation of a sequential treatment strategy in women with recurrent major depression Journal of Clinical Psychiatry 61(1): 51-57
Wroblewski, B.A.; Joseph, A.B.; Cornblatt, R.R. 1996: Antidepressant pharmacotherapy and the treatment of depression in patients with severe traumatic brain injury: a controlled, prospective study Journal of Clinical Psychiatry 57(12): 582-587
Ketter, T.A.; Post, R.M.; Parekh, P.I.; Worthington, K. 1995: Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression Journal of Clinical Psychiatry 56(10): 471-475
Thase, M.E. 2007: Introduction: new directions in the treatment of atypical depression Journal of Clinical Psychiatry 68 Suppl. 3: 4-9
Sussman, N.; Joffe, R.T. 1998: Introduction: augmentation of antidepressant medication Journal of Clinical Psychiatry 59 Suppl. 5: 3-4; Discussion 70-3
Dudek, D.; Siwek, M.; Borowiecka-Kluza, J. 2008: The analysis of bipolar spectrum features in drug resistant unipolar depression patients as compared to depressive patients who responded to standard antidepressant treatment. a pilot study Psychiatria Polska 42(2): 283-294
Nemeroff, C.B. 1993: Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression Journal of Clinical Psychopharmacology 13(6 Suppl 2): 10s-17s
Ostacher, M.J. 2006: The evidence for antidepressant use in bipolar depression Journal of Clinical Psychiatry 67(Suppl 11): 18-21